Gregory B. Lesinski, PhD, MPH

Professor, Co-Director Translational GI Malignancy Program
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University

Poster(s):

• E193: Expanding immunotherapy options in cholangiocarcinoma: Role of CD27 agonist in combination with PD-L1 and MEK inhibition on antitumor effect and CD8+ T cells

• E318: CD26 is a biomarker that can enhance response to T cell therapy in advanced melanoma